Insulet Corporation Announces $450M Senior Notes Offering
Acton, MA – March 18, 2025 – Insulet Corporation (NASDAQ: PODD) has announced the pricing of $450 million in senior unsecured notes due 2033 through a private placement offering.

Key Highlights:
Use of Proceeds:
The funds will be used to redeem, repurchase, or repay all or part of Insulet's 0.375% Convertible Senior Notes due 2026.
A portion may also be used for general corporate purposes and to cover expenses related to the offering.
Expected Closing Date: March 20, 2025, subject to standard closing conditions.
Investor Eligibility: The notes are being offered only to qualified institutional buyers under Rule 144A and non-U.S. investors under Regulation S.
Forward-Looking Statements:
Insulet emphasized that actual outcomes may differ from expectations due to market conditions and regulatory requirements. The company does not consider this announcement an offer to sell or repurchase securities but rather a disclosure of its financial strategy.

This move reflects Insulet's commitment to financial flexibility and long-term growth in the medical technology sector.